PK study of Fluticasone/Salmeterol combinations (329/210)

• Research type

  Research Study

• Full title

  A Phase I Pilot Pharmacokinetic Study in Healthy Subjects of Fluticasone Propionate/Salmeterol Xinafoate Combinations Administered as Dry Powders in Solis™ versus Diskus®

• IRAS ID

  144982

• Contact name

  Olufeyikemi Oluwayi

• Contact email

  Olufeyikemi.Oluwayi@quintiles.com

• Sponsor organisation

  Oriel Therapeutics Inc

• Eudract number

  2013-004853-26

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  14/SC/0018

• Date of REC Opinion

  29 Jan 2014

• REC opinion

  Further Information Favourable Opinion